Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-23 · accession 0001556327-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-23 | VRCA | Kirby John J. | Interim CFO | A - Grant | $0.00 | +10.0K | 19.0K | +112% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-23 | A | A | 10,000 | $0.00 | 18,962 | D | — | — | (F1) Represents a fully vested restricted stock unit award. |